ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

LucyRx Expands Executive Team

Strategic appointments support rapid growth with proven leadership in core operating areas

LucyRx, a next-generation pharmacy benefits manager (PBM) committed to simplifying and improving access to prescription care, recently added four healthcare industry veterans to expand core operations, including legal, sales and government programs as the company continues its rapid growth nationwide.

With patient-focused and fairly priced pharmacy benefits in high demand, LucyRx has grown quickly, now covering more than one million members with 1,200 health plan clients across the U.S.

These healthcare veterans add valuable depth to support the company’s growth—as more organizations choose its member-centered, technology-driven approach to prescription benefits.

  • Paul Brown, Chief Legal Officer and General Counsel, will oversee the company’s legal strategy, compliance and risk management. Paul brings extensive experience in regulatory compliance, commercial transactions and M&A execution and integration from prior roles at Kaufman Hall (a Vizient company) and UL Solutions.
  • Michael McCarrell, Chief Operating Officer, will lead all core operational areas including customer service, claims administration and clinical operations. Michael brings over 25 years of healthcare leadership experience, most recently as President and COO of CPS Solutions, where he led the nation’s largest hospital pharmacy services provider.
  • Crescent Moore, Senior Vice President of Government Programs, will lead LucyRx’s expansion into Medicare and other government-sponsored markets. Crescent brings nearly two decades of leadership in Medicare Part D and clinical strategy, most recently as Director Part D/Pharmacy at BluePeak Advisors.
  • Cody Field, Senior Vice President of Employer Sales, joins LucyRx with a strong background in clinical care, account management, and business development. Most recently at Marsh McLennan, Cody brings a patient-first mindset and deep healthcare experience that will further strengthen LucyRx’s partnerships with employers nationwide.

“Each of these leaders brings significant experience to ensure LucyRx is the most innovative, highest performing, patient-centered prescription benefit provider in the industry,” said David Blair, CEO of LucyRx. “With Mike, Paul, Crescent and Cody on board, we’re well positioned to bring our vision to life: prescription care, brilliantly reimagined.”

About LucyRx

LucyRx is an independent, next-generation pharmacy benefit manager (PBM) redefining prescription care. Fueled by innovation and decades of leadership experience, LucyRx delivers better outcomes through its integrated specialty network, formulary marketplace, and next-day home delivery solutions. Powered by its proprietary AI platform, LucyIQ™, the company provides real-time insights that support evidence-based clinical decisions, clear pricing, and exceptional service from U.S.-based pharmacy technicians. Partnering with more than 60,000 pharmacies, LucyRx serves over 1,200 clients nationwide.

This is prescription care, brilliantly reimagined.

Learn more at LucyRx.com.

With patient-focused and fairly priced pharmacy benefits in high demand, LucyRx has grown quickly, now covering more than one million members with 1,200 health plan clients across the U.S.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.77
-0.80 (-0.38%)
AAPL  255.92
+0.29 (0.11%)
AMD  217.50
+7.29 (3.47%)
BAC  49.38
+0.11 (0.22%)
GOOG  294.46
-0.44 (-0.15%)
META  574.46
-4.77 (-0.82%)
MSFT  373.46
+4.09 (1.11%)
NVDA  177.39
+1.64 (0.93%)
ORCL  146.38
+1.15 (0.79%)
TSLA  360.59
-20.67 (-5.42%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.